Fig. 4From: The pharmacokinetics, bioavailability and excretion of bergapten after oral and intravenous administration in rats using high performance liquid chromatography with fluorescence detectionTime cumulative excretion percentage of bergapten (a1) in urine, (b1) in feces and (c1) in bile; cumulative excretion percentage at different time of bergapten (a2) in urine, (b2) in feces and (c2) in bileBack to article page